Vaccine For Pcv2 And Mycoplasma

Patent No. EP2994162 (titled "Vaccine For Pcv2 And Mycoplasma") was filed by Pharmgate Biologics on May 8, 2014. The application was issued on Apr 7, 2021.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
BOEHRINGER INGELHEIM VETMEDICA	Jan 7, 2022	HOFFMANN EITLE
BOEHRINGER INGELHEIM	Jan 7, 2022	HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Oct 13, 2025
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Oct 13, 2025
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jul 10, 2025
Brief communication - Opposition proceedings
Jul 10, 2025
Brief communication - Opposition proceedings
Jul 10, 2025
Decision of the Opposition Division and instruction
Jul 10, 2025
Decision revoking the European patent
Jul 10, 2025
Decision revoking the European patent
Jul 10, 2025
Grounds for the decision (Annex) - opposition
Jul 10, 2025
Means of redress
Jul 10, 2025
Scanned annex to a communication - opposition procedure
Aug 20, 2024
Brief communication - Opposition proceedings
Aug 14, 2024
(Electronic) Receipt
Aug 14, 2024
Letter accompanying subsequently filed items
Aug 14, 2024
Reply to an examination report in opposition proceedings
Apr 15, 2024
Annex to the communication - opposition
Apr 15, 2024
Brief communication - Opposition proceedings
Apr 15, 2024
Brief communication - Opposition proceedings
Apr 15, 2024
Communication inviting the parties to file observations
Apr 15, 2024
Communication inviting the parties to file observations
Jan 19, 2022
Communication of a notice of opposition and request to file observations
Jan 19, 2022
Notice of further oppositions to opponent(s)
Jan 13, 2022
Communication of a notice of opposition - first information to patent proprietor
Jan 7, 2022
(Electronic) Receipt
Jan 7, 2022
Citation in opposition procedure - 001
Jan 7, 2022
Citation in opposition procedure - 002
Jan 7, 2022
Citation in opposition procedure - 003
Jan 7, 2022
Citation in opposition procedure - 004
Jan 7, 2022
Citation in opposition procedure - 004
Jan 7, 2022
Citation in opposition procedure - 005
Jan 7, 2022
Citation in opposition procedure - 006
Jan 7, 2022
Citation in opposition procedure - 006
Jan 7, 2022
Citation in opposition procedure - 007
Jan 7, 2022
Citation in opposition procedure - 008
Jan 7, 2022
Citation in opposition procedure - 009
Jan 7, 2022
Citation in opposition procedure - 010
Jan 7, 2022
Citation in opposition procedure - 011
Jan 7, 2022
Citation in opposition procedure - 012
Jan 7, 2022
Citation in opposition procedure - 013
Jan 7, 2022
Citation in opposition procedure - 014
Jan 7, 2022
Citation in opposition procedure - 015
Jan 7, 2022
Citation in opposition procedure - 016
Jan 7, 2022
Citation in opposition procedure - 017
Jan 7, 2022
Citation in opposition procedure - 018
Jan 7, 2022
Citation in opposition procedure - 019
Jan 7, 2022
Citation in opposition procedure - 020
Jan 7, 2022
Citation in opposition procedure - 021
Jan 7, 2022
Citation in opposition procedure - 022
Jan 7, 2022
Citation in opposition procedure - 023
Jan 7, 2022
Citation in opposition procedure - 024
Jan 7, 2022
Citation in opposition procedure - 025
Jan 7, 2022
Citation in opposition procedure - 025
Jan 7, 2022
Citation in opposition procedure - 026
Jan 7, 2022
Citation in opposition procedure - 027
Jan 7, 2022
Citation in opposition procedure - 028
Jan 7, 2022
Citation in opposition procedure - 029
Jan 7, 2022
Citation in opposition procedure - 030
Jan 7, 2022
Citation in opposition procedure - 031
Jan 7, 2022
Citation in opposition procedure - 032
Jan 7, 2022
Consolidated list of cited opposition documents
Jan 7, 2022
Notice of opposition
Jan 7, 2022
Notice of opposition
May 11, 2021
Payment submission rejected
Apr 20, 2021
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Mar 12, 2021
Decision to grant a European patent
Feb 26, 2021
(Electronic) Receipt
Feb 26, 2021
Filing of the translations of the claims
Feb 26, 2021
French translation of claims
Feb 26, 2021
German translation of the claims
Feb 26, 2021
Letter accompanying subsequently filed items
Oct 29, 2020
Bibliographic data of the European patent application
Oct 29, 2020
Communication about intention to grant a European patent
Oct 29, 2020
Intention to grant (signatures)
Oct 29, 2020
Text intended for grant (clean copy)
Oct 29, 2020
Text intended for grant (sequence listing)
Oct 29, 2020
Text intended for grant (version for approval)
Sep 14, 2020
(Electronic) Receipt
Sep 14, 2020
Abstract
Sep 14, 2020
Abstract
Sep 14, 2020
Amended claims with annotations
Sep 14, 2020
Amended description with annotations
Sep 14, 2020
Claims
Sep 14, 2020
Description
Sep 14, 2020
Letter accompanying subsequently filed items
Sep 14, 2020
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Jul 27, 2020
Bibliographic data of the European patent application
Jul 27, 2020
Communication about intention to grant a European patent
Jul 27, 2020
Intention to grant (signatures)
Jul 27, 2020
Text intended for grant (clean copy)
Jul 27, 2020
Text intended for grant (sequence listing)
Jul 27, 2020
Text intended for grant (version for approval)
Jun 24, 2020
Annex to a communication
Jun 24, 2020
Annex to a communication
Jun 24, 2020
Annex to a communication
Jun 24, 2020
Annex to the communication
Jun 24, 2020
Minutes of the oral proceedings (examining division)
Jun 24, 2020
Minutes of the oral proceedings (examining division)
Jun 24, 2020
Provision of a copy of the minutes of oral proceedings
Jun 17, 2020
(Electronic) Receipt
Jun 17, 2020
Abstract
Jun 17, 2020
Abstract
Jun 17, 2020
Amended claims with annotations
Jun 17, 2020
Amended description with annotations
Jun 17, 2020
Claims
Jun 17, 2020
Description
Jun 17, 2020
Letter accompanying subsequently filed items
Jun 17, 2020
Minutes of the oral proceedings (examining division)
Jun 17, 2020
Written submission in preparation to/during oral proceedings
Jun 15, 2020
Amended claims with annotations
Jun 15, 2020
Amended claims with annotations
Jun 15, 2020
Claims submitted during oral proceedings
Jun 15, 2020
Written submission in preparation to/during oral proceedings
Jun 9, 2020
(Electronic) Receipt
Jun 9, 2020
Amended claims with annotations
Jun 9, 2020
Amended claims with annotations
Jun 9, 2020
Amended claims with annotations
Jun 9, 2020
Amended claims with annotations
Jun 9, 2020
Amended claims with annotations
Jun 9, 2020
Annex
Jun 9, 2020
Annex
Jun 9, 2020
Annex
Jun 9, 2020
Annex
Jun 9, 2020
Annex
Jun 9, 2020
Annex
Jun 9, 2020
Claims
Jun 9, 2020
Claims
Jun 9, 2020
Claims
Jun 9, 2020
Claims
Jun 9, 2020
Claims
Jun 9, 2020
Letter accompanying subsequently filed items
Jun 9, 2020
Non-patent literature cited during the examination procedure
Jun 9, 2020
Non-patent literature cited during the examination procedure
Jun 9, 2020
Non-patent literature cited during the examination procedure
Jun 9, 2020
Non-patent literature cited during the examination procedure
Jun 9, 2020
Written submission in preparation to/during oral proceedings
May 8, 2020
Annex to the communication
May 8, 2020
Consultation by telephone/in person
May 8, 2020
Result of consultation by telephone/in person
Apr 15, 2020
(Electronic) Receipt
Apr 15, 2020
Amended claims with annotations
Apr 15, 2020
Amended claims with annotations
Apr 15, 2020
Amended claims with annotations
Apr 15, 2020
Annex
Apr 15, 2020
Claims
Apr 15, 2020
Claims
Apr 15, 2020
Claims
Apr 15, 2020
Letter accompanying subsequently filed items
Apr 15, 2020
Non-patent literature cited during the examination procedure
Apr 15, 2020
Written submission in preparation to/during oral proceedings
Mar 5, 2020
Advice of delivery
Mar 3, 2020
Acknowledgement of a document
Mar 3, 2020
Annex to the communication
Mar 3, 2020
Notification concerning the date of oral proceedings
Mar 3, 2020
Summons to attend oral proceedings
Feb 25, 2020
(Electronic) Receipt
Feb 25, 2020
Letter accompanying subsequently filed items
Feb 25, 2020
Oral proceedings: Request for postponement
Feb 11, 2020
(Electronic) Receipt
Feb 11, 2020
Letter accompanying subsequently filed items
Feb 11, 2020
Oral proceedings: Request for postponement
Jan 15, 2020
Advice of delivery
Jan 15, 2020
Advice of delivery
Jan 13, 2020
Communication about missing advice of delivery
Nov 27, 2019
Acknowledgement of a document
Nov 27, 2019
Annex to the communication
Nov 27, 2019
Summons to attend oral proceedings
Oct 4, 2019
Communication of the registration of a transfer or change of name and/or address
Sep 2, 2019
(Electronic) Receipt
Sep 2, 2019
Annexes in respect of a client data request
Sep 2, 2019
Authorisation
Sep 2, 2019
Letter accompanying subsequently filed items
Sep 2, 2019
Submission concerning change of applicant's name
Aug 13, 2019
Communication concerning the filing of a power of attorney
Aug 13, 2019
Communication of amended entries concerning the representative
Aug 7, 2019
(Electronic) Receipt
Aug 7, 2019
Authorisation
Aug 7, 2019
Letter accompanying subsequently filed items
Aug 7, 2019
Submission concerning change of applicant's representative
Jul 17, 2019
(Electronic) Receipt
Jul 17, 2019
Amended claims with annotations
Jul 17, 2019
Claims
Jul 17, 2019
Letter accompanying subsequently filed items
Jul 17, 2019
Reply to communication from the Examining Division
May 9, 2019
Annex to the communication
May 9, 2019
Communication from the Examining Division
May 3, 2019
Examination started
Oct 30, 2017
Decision to allow further processing
Oct 17, 2017
(Electronic) Receipt
Oct 17, 2017
Amended claims filed after receipt of (European) search report
Oct 17, 2017
Amended claims with annotations
Oct 17, 2017
Letter accompanying subsequently filed items
Oct 17, 2017
Matter concerning the application
Oct 17, 2017
Matter concerning the application
Oct 17, 2017
Request for further processing
Aug 8, 2017
Application deemed to be withdrawn (no declaration of maintenance of the application/non-reply to the Written Opinion)
Dec 9, 2016
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Nov 23, 2016
Communication regarding the transmission of the European search report
Nov 23, 2016
European search opinion
Nov 23, 2016
Information on Search Strategy
Nov 23, 2016
Supplementary European search report
Nov 2, 2016
Search started
Feb 17, 2016
Notification on forthcoming publication of bibliographic data
Dec 17, 2015
Communication regarding possible amendment of the application/payment of claims fee
Dec 11, 2015
Communication to designated inventor
Dec 11, 2015
Communication to designated inventor
Nov 25, 2015
(Electronic) Receipt
Nov 25, 2015
Converted Sequence Listing
Nov 25, 2015
Request for entry into the European phase
Nov 23, 2015
Copy of the international preliminary report on patentability
Sep 18, 2015
Information on entry into European phase
Dec 2, 2014
Priority document (electronically transmitted)
Nov 13, 2014
Converted Sequence Listing
Nov 13, 2014
Copy of the international search report
Nov 13, 2014
Published international application - A1

EP2994162

PHARMGATE BIOLOGICS

Application Number: EP14794866A
Filing Date: May 8, 2014
Status: Revoked; Oct 17, 2025
Publication Date: Apr 7, 2021
External Links: Slate, Register , Google Patents

IP Verse

Vaccine For Pcv2 And Mycoplasma

Patent Summary

Patent Family

Patent Oppositions (2)

Dossier Documents

EP2994162